Huafon Chemical Co Ltd

Huafon Chemical maintains a conservative capital structure, with a debt-to-equity ratio of 0.10, significantly below the median for the specialty chemicals industry. The company’s liquidity position is moderate, with a current ratio of 2.55, indicating sufficient short-term assets to cover liabilities. However, free cash flow of 577 million CNY is constrained by capital expenditures of -1.72 billion CNY, suggesting ongoing investment in operational capacity. Profitability metrics show a return on equity (ROE) of 6.79% and return on assets (ROA) of 5.04%, both below the industry median for specialty chemicals. Gross profit of 3.18 billion CNY and operating income of 2.37 billion CNY reflect a narrow margin profile, consistent with competitive pricing pressures in the sector. Geographic and segment exposure is not explicitly disclosed, but the company’s revenue concentration in China is implied by its domestic operations and supply chain. No material international revenue streams are reported, which may limit diversification benefits in a volatile global market. Growth trajectory is modest, with no explicit guidance provided for the current or next fiscal year. Analysts project a mean price target of 12.88 CNY, with a median of 12.88 CNY, and a mean recommendation of 1.40 (strong buy to buy). However, the absence of revenue growth data in the latest filing suggests a stable but not accelerating business model. Risk factors include moderate liquidity risk due to negative net cash after subtracting total debt, and low dilution risk, with no near-term pressure from share issuance. The company’s capital expenditures are funded internally, and no dilutive financing is disclosed in recent filings. Recent events include a 10-K filing that outlines operational risks, including raw material price volatility and regulatory compliance. No material earnings call transcripts or press releases were available in the latest data window.